155 related articles for article (PubMed ID: 1709970)
1. Expression of mucin type carbohydrates may supplement histologic diagnosis in oral premalignant lesions.
Bryne M; Reibel J; Mandel U; Dabelsteen E
J Oral Pathol Med; 1991 Mar; 20(3):120-5. PubMed ID: 1709970
[TBL] [Abstract][Full Text] [Related]
2. Premalignant oral mucosal diseases.
Melrose RJ
J Calif Dent Assoc; 2001 Aug; 29(8):593-600. PubMed ID: 11577670
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of MUC1 mucin in premalignant oral lesions and oral squamous cell carcinoma: association with disease progression, mode of invasion, and lymph node metastasis.
Nitta T; Sugihara K; Tsuyama S; Murata F
Cancer; 2000 Jan; 88(2):245-54. PubMed ID: 10640953
[TBL] [Abstract][Full Text] [Related]
4. MAGE-A antigens in lesions of the oral mucosa.
Krauss E; Rauthe S; Gattenlöhner S; Reuther T; Kochel M; Kriegebaum U; Kübler AC; Müller-Richter UD
Clin Oral Investig; 2011 Jun; 15(3):315-20. PubMed ID: 20174843
[TBL] [Abstract][Full Text] [Related]
5. Reactivity of monoclonal antibodies 17.13 and 63.12 with oral epithelial dysplasia and hyperkeratosis.
Merrell P; Carpenter W; Silverman S; Leider A; Gallo J
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Mar; 83(3):367-72. PubMed ID: 9084201
[TBL] [Abstract][Full Text] [Related]
6. Simple mucin-type carbohydrates in oral stratified squamous and salivary gland epithelia.
Mandel U; Petersen OW; Sørensen H; Vedtofte P; Hakomori S; Clausen H; Dabelsteen E
J Invest Dermatol; 1991 Oct; 97(4):713-21. PubMed ID: 1940443
[TBL] [Abstract][Full Text] [Related]
7. Risk factors and etiopathogenesis of potentially premalignant oral epithelial lesions.
Porter S; Gueiros LA; Leão JC; Fedele S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):603-611. PubMed ID: 29891084
[TBL] [Abstract][Full Text] [Related]
8. The expression of cell surface MHC class I heavy and light chain molecules in pre-malignant and malignant lesions of the oral mucosa.
Prime SS; Pitigala-Arachchi A; Crane IJ; Rosser TJ; Scully C
Histopathology; 1987 Jan; 11(1):81-91. PubMed ID: 3549515
[TBL] [Abstract][Full Text] [Related]
9. Premalignant and malignant oral lesions are associated with changes in the glycosylation pattern of carbohydrates related to ABH blood group antigens.
Dabelsteen E; Clausen H; Holmstrup P; Reibel J
APMIS; 1988 Sep; 96(9):813-9. PubMed ID: 3048339
[TBL] [Abstract][Full Text] [Related]
10. Premalignant lesions of the oral mucosa.
Jolly M
Aust Dent J; 1976 Oct; 21(5):414-22. PubMed ID: 1070974
[TBL] [Abstract][Full Text] [Related]
11. Oral epithelial dysplasia and the development of invasive squamous cell carcinoma.
Lumerman H; Freedman P; Kerpel S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Mar; 79(3):321-9. PubMed ID: 7621010
[TBL] [Abstract][Full Text] [Related]
12. [Immunopathology of the oral mucosa. Oral immune system--inflammatory reactions--tumor-"marker"--virus identification].
Löning T
Veroff Pathol; 1984; 121():1-178. PubMed ID: 6322469
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
[TBL] [Abstract][Full Text] [Related]
14. Is the carbohydrate sialosyl-Tn a marker for altered, non-malignant activity in squamous epithelium in the head and neck region?
Bryne M; Gravdahl C; Koppang HS; Kjaerheim A; Dabelsteen E
J Pathol; 1995 Feb; 175(2):237-42. PubMed ID: 7738720
[TBL] [Abstract][Full Text] [Related]
15. Langerhans cells in epithelial tumors and benign lesions of the oropharynx.
Girod SC; Kühnast T; Ulrich S; Krueger GR
In Vivo; 1994; 8(4):543-7. PubMed ID: 7893981
[TBL] [Abstract][Full Text] [Related]
16. Special focus issue on potentially premalignant oral epithelial lesions: introduction and perspective.
Nikitakis NG
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):575-576. PubMed ID: 29699945
[No Abstract] [Full Text] [Related]
17. Histological and immunochemical studies of oral leukoplakia: phenotype and distribution of immunocompetent cells.
Bondad-Palmario GG
J Philipp Dent Assoc; 1995; 47(1):3-18. PubMed ID: 9227108
[TBL] [Abstract][Full Text] [Related]
18. Management update of potentially premalignant oral epithelial lesions.
Awadallah M; Idle M; Patel K; Kademani D
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):628-636. PubMed ID: 29656948
[TBL] [Abstract][Full Text] [Related]
19. [Leukoplakia and erythroplakia--two orale precursor lesions].
Grajewski S; Groneberg D
Laryngorhinootologie; 2009 Oct; 88(10):666-72; quiz 673-5. PubMed ID: 19813163
[TBL] [Abstract][Full Text] [Related]
20. Pathology of malignant and premalignant oral epithelial lesions.
Greer RO
Otolaryngol Clin North Am; 2006 Apr; 39(2):249-75, v. PubMed ID: 16580910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
